english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2019 Recap > Drug-device combinations: EMA's consultation on quality requirements is an opportunity to strengthen patient safety (8/2019)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2019
Drug-device combinations: EMA's consultation on quality requirements is an opportunity to strengthen patient safety (August 2019)

Paris, 30 August 2019

Drug-device combinations play a major role in preventing medication errors. The public consultation relating to the draft Guideline for the quality requirements for drug-device combinations is an opportunity for EMA to significantly strengthen its expertise in these health products and patient safety. Prescrire offers a series of recommendations mainly aimed at protecting children, elderly patients, and patients undergoing high-risk hospital care.

> Click here to download Prescrire's response (pdf, 146 Ko)
 

©Prescrire August 2019

Share Share on Facebook Share on Twitter